title: Mineral deficiency and the use of the FETAX bioassay to study environmental teratogens.
abstract: The Frog Embryo Teratogenesis Assay: Xenopus (FETAX) bioassay has been employed extensively to screen compounds for teratogenic activity. Recent laboratory studies have indicated that low potassium concentrations retard Xenopus laevis development. The effects of varying concentrations of minerals on Xenopus laevis embryo length and development were examined to determine the utility of the FETAX bioassay in the study of environmental teratogens. Water samples collected from 18 wetlands in Minnesota and North Dakota correlated with low mineral levels, causing delayed embryonic development in the FETAX bioassay. When the concentration of sodium or potassium was <5 ppm, Xenopus laevis development was delayed. As a result, it was difficult to assess teratogenic activity after 96 h of incubation. Furthermore, the length of the embryos-an indication of development-paralleled changes in mineral composition. Comparisons between different wetlands based on changes in one specific mineral were not possible due to a synergism between various minerals. If the concentration of sodium and/or potassium was <5 ppm but > or =2 ppm, extension of the FETAX bioassay to 120 h allowed organogenesis to proceed through stage 46, as required for scoring in accordance with ASTM guidelines for the FETAX bioassay. In those cases in which the concentration of sodium and/or potassium were <2 ppm, the embryos could not develop to stage 46 within 120 h and the FETAX bioassay was not suitable for detecting teratogenic activity. Published in 2002 by John Wiley & Sons, Ltd.
authors.affiliation: USDA-ARS, Biosciences Research Laboratory, 1605 Albrecht Blvd., Fargo, ND 58105, USA. garbere@hotmail.com
authors.forename: Eric A E
authors.initials: EA
authors.lastname: Garber
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004625:Embryo, Nonmammalian / Q000002:abnormalities / Q000187:drug effects*; D047108:Embryonic Development; D023381:Endpoint Determination; D005618:Fresh Water / Q000032:analysis; D008903:Minerals / Q000032:analysis / Q000494:pharmacology*; D008910:Minnesota; D009658:North Dakota; D011188:Potassium / Q000494:pharmacology; D011191:Potassium Deficiency; D015203:Reproducibility of Results; D012964:Sodium / Q000172:deficiency / Q000494:pharmacology; D013723:Teratogens / Q000633:toxicity*; D018675:Toxicity Tests; D014874:Water Pollutants, Chemical / Q000633:toxicity*; D014982:Xenopus laevis
chemical_list: D008903:Minerals; D013723:Teratogens; D014874:Water Pollutants, Chemical; D012964:Sodium; D011188:Potassium